ArticleBiomedicines2023

Two-Time Multiplexed Targeted Next-Generation Sequencing Might Help the Implementation of Germline Screening Tools for Myelodysplastic Syndromes/Hematologic Neoplasms.

Oriol Calvete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.